Intrinsic Value of S&P & Nasdaq Contact Us

Zimmer Biomet Holdings, Inc. ZBH NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
63/100
2/7 Pass
SharesGrow Intrinsic Value
$108.60
+12.5%
Analyst Price Target
$105.60
+9.4%

Zimmer Biomet Holdings, Inc. (ZBH) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Warsaw, IN, United States. The current CEO is Ivan Tornos.

ZBH has IPO date of 2001-07-25, 17,000 full-time employees, listed on the NYSE, a market capitalization of $18.88B.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a global musculoskeletal healthcare company that designs, manufactures, and markets a comprehensive portfolio of medical devices and surgical solutions. The company's core offerings include orthopaedic reconstructive products for knees and hips, spine devices, sports medicine and trauma products, dental implants and regenerative solutions, as well as robotic-assisted surgical systems and bone cement products. Zimmer Biomet serves orthopedic surgeons, neurosurgeons, dentists, hospitals, and healthcare systems across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Founded in 1927 and headquartered in Warsaw, Indiana, the company addresses treatment needs for patients with bone, joint, and soft tissue disorders through innovative surgical and therapeutic solutions.

📍 345 East Main Street, Warsaw, IN 46580 📞 574 267 6131
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryUnited States
ExchangeNYSE
CurrencyUSD
IPO Date2001-07-25
CEOIvan Tornos
Employees17,000
Trading Info
Current Price$96.52
Market Cap$18.88B
52-Week Range84.59-108.51
Beta0.61
ETFNo
ADRNo
CUSIP98956P102
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message